Roger Askew
Molecular and Cell Biology
Ozgene
Australia
Biography
Roger joined the Ozgene team in May 2015 as Ozgene's Principal Scientist North America. He is based in Boston, MA. Roger comes to us with twenty years of industry experience developing and phenotyping genetically engineered models (GEMs) in collaborative support of the Therapeutic Areas (TAs) at three pharmaceutical companies. Roger received his PhD from Wesleyan University, Dept of Molecular Biology and Biochemistry and spent his post-doctoral days at the University of Cincinnati Medical School in the laboratories or Drs Jerry Lingrel and Thomas Doetschman where he developed the gene-targeted “Tag-and-Echage" strategy for knocking in subtle mutations, including point mutations, into the mouse genome.
Research Interest
Molecular and Cell Biology
